Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00126
|
|||||
| EM Name |
Alpha-ketoglutarate
|
|||||
| Synonyms |
ketoglutarate; alpha-ketoglutarate; 2-oxopentanedioate; Pentanedioic acid, 2-oxo-, ion(2-); 2-oxopentanedionate; 2-Oxoglutamate; alphaketoglutarate; alpha-oxoglutarate; 3hww; 2xzw; Pentanedioic acid,2-oxo-, ion(2-); .alpha.-ketoglutarate; 2-oxoglutarate(2-); 2-oxopentanedionic acid; AC1L4UYD; 4-Carboxy-2-oxo-butyrate; AC1Q28OE; CTK5C0826; DTXSID80213974; KPGXRSRHYNQIFN-UHFFFAOYSA-L; 2-oxopentanedioic acid, ion(2-); 4-Carboxy-2-oxo-butyric acid anion; CJ-24197; CJ-05247
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=164533"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H4O5-2
|
|||||
| Canonical SMILES |
C(CC(=O)[O-])C(=O)C(=O)[O-]
|
|||||
| InChI |
InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)/p-2
|
|||||
| InChIKey |
KPGXRSRHYNQIFN-UHFFFAOYSA-L
|
|||||
| CAS Number |
CAS 64-15-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 144.08 | Topological Polar Surface Area | 97.3 | ||
| Heavy Atom Count | 10 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 5 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:16810
|
|||||
| DT(s) "handling" This EM | GC1 | Transporter Info | Mitochondrial glutamate carrier 1 | [1] | ||
| OAT1 | Transporter Info | Organic anion transporter 1 | [2] | |||
| SLC7A11 | Transporter Info | Cystine/glutamate transporter | [3] | |||
| References | ||||||
| 1 | LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer. Oncotarget. 2017 Sep 20;8(60):101333-101344. | |||||
| 2 | Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J Biol Chem. 2006 Feb 24;281(8):5072-83. | |||||
| 3 | The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. J Biol Chem. 2017 Aug 25;292(34):14240-14249. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.